Clinical Trial Update: A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of ranibizumab 10 mg/mL injections for diabetic macular edema is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Macular Edema
• Diabetic Retinopathy
• Macular Edema
• Retinal Degeneration
• Retinal Disease

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Incepta Pharmaceuticals Ltd | Conditions: Diabetic Macular Edema, Diabetic Retinopathy | Phase 3 | Status: RECRUITING